Management Consulting

Integrated Launch Planning

A fully coordinated, holistic approach

Benefit from Alira Health’s full spectrum of strategy and advisory services to ensure successful outcomes for all of your business stakeholders: patients, providers, payers, and suppliers.

Elevating industry best practices and innovation

Integrated launch planning (ILP) is recognized as an essential best practice. Alira Health provides full spectrum support to coordinate key launch deliverables in a transparent, collaborative way. This allows functions and markets across your organization to focus on the path towards launch in a more holistic, integrated way—a critical key to success.

The purpose of the ILP is not to replace functional launch plans—it’s to provide high-level leadership that delivers an integrated view of the whole picture. As your partner, Alira Health will highlight potential needs for analysis and inquiry if delays are anticipated.

Why choose Alira Health?

Whether your in-house teams are launching products across a multitude of therapeutic areas or you’re a BioTech company relying on third-party service providers, we will help you translating your launch strategy into a robust, executable plan.

Our experienced global team will actively engage with your organization to:

  • Structure your launch preparations and define appropriate launch governance
  • Meet with critical workstream teams to identify key deliverables and essential interdependencies
  • Deliver an integrated launch plan tool that is easy to update and provides customized status reports

Related news

Publications May 25, 2023
The EU Pharmaceutical Package: Introduction to Changes
Alira Health’s Regulatory experts explore how the proposed package will disrupt the European regulatory landscape and what it means for companies.
EU Pharma Regulatory
Events May 16, 2023
PSI 2023 Conference
We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.
Orphan Drug Pharma Rare Disease UK
Events May 15, 2023
World Orphan Drug Congress USA
We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.
Orphan Drug Pharma Rare Disease
Events May 15, 2023
BIO International Convention
We are excited to share that we will be attending the BIO International Convention in Boston. This leading industry event attracts biotechnology and pharma leaders for one week of intensive(...)
Biotech Pharma
Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Blog April 14, 2023
Lifecycle Optimization: The Path to Commercial Success
Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?
Market Access MedTech Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.